Vimarsana
Biggest News Aggregation in the World

Page 23 - Ipid Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ipid Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ipid Management Today - Breaking & Trending Today

Immediate Statin After Acute Stroke Reduces Disability - Vimarsana News

Immediate Statin After Acute Stroke Reduces Disability

Intensive statin therapy immediately after mild ischemic stroke or high-risk TIA reduces the risk for a poor functional outcome vs delaying 72 hours, the INSPIRES trial shows.

Microscopic Colitis Raises Risk for Cardiac Events - Vimarsana News

Microscopic Colitis Raises Risk for Cardiac Events

A large Swedish study found a higher risk for major adverse cardiovascular events among patients with microscopic colitis compared to the general population.

High Lp(a) Tied to Higher Coronary Plaque, Progression - Vimarsana News

High Lp(a) Tied to Higher Coronary Plaque, Progression

Both coronary plaque burden and the rate of plaque progression are increased in patients with high Lp(a) levels, potentially explaining the link with higher CV risk, new findings suggest.

More Work Needed to Achieve LDL Goals: SANTORINI - Vimarsana News

More Work Needed to Achieve LDL Goals: SANTORINI

Though 10% more patients in the SANTORINI registry achieved their lipid goal after 1 year thanks to increased use of combination therapies, the results are still "very disappointing," says one expert.

URAT1 Inhibitor Shows 'Substantial' Cut in Uric Acid in Gout - Vimarsana News

URAT1 Inhibitor Shows 'Substantial' Cut in Uric Acid in Gout

The investigational drug AR882 reduced serum uric acid to levels seen in people without hyperuricemia and gout.